RNF8 identified as a co-activator of estrogen receptor α promotes cell growth in breast cancer.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Biochimica et Biophysica Acta - Molecular Basis of Disease

• Publication date

  2017-06-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.bbadis.2017.02.011PMID 28216286
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The DNA Damage Transducer RNF8 Facilitates Cancer Chemoresistance and Progression through Twist Activation.

  2016cited by this paper
• Adenovirus-mediated downregulation of the ubiquitin ligase RNF8 sensitizes bladder cancer to radiotherapy

  2016cited by this paper
• The NSL Chromatin-Modifying Complex Subunit KANSL2 Regulates Cancer Stem-like Properties in Glioblastoma That Contribute to Tumorigenesis.

  2016cited by this paper
• RNF8 promotes epithelial-mesenchymal transition of breast cancer cells

  2016cited by this paper
• A Preclinical Model for ERα-Positive Breast Cancer Points to the Epithelial Microenvironment as Determinant of Luminal Phenotype and Hormone Response.

  2016cited by this paper
• RNF8 deficiency results in neurodegeneration in mice.

  2015cited by this paper
• ATDC (Ataxia Telangiectasia Group D Complementing) Promotes Radioresistance through an Interaction with the RNF8 Ubiquitin Ligase*

  2015cited by this paper
• Estrogen receptor alpha phosphorylation and its functional impact in human breast cancer.

  2015cited by this paper
• HOXB7 Is an ERα Cofactor in the Activation of HER2 and Multiple ER Target Genes Leading to Endocrine Resistance.

  2015cited by this paper
• MEL-18 loss mediates estrogen receptor-α downregulation and hormone independence.

  2015cited by this paper
• MDC1 functionally identified as an androgen receptor co-activator participates in suppression of prostate cancer

  2015cited by this paper
• RNF8 plays an important role in the radioresistance of human nasopharyngeal cancer cells in vitro.

  2015cited by this paper
• Structural analysis of the KANSL1/WDR5/KANSL2 complex reveals that WDR5 is required for efficient assembly and chromatin targeting of the NSL complex

  2014cited by this paper
• The atypical ubiquitin ligase RNF31 stabilizes estrogen receptor α and modulates estrogen-stimulated breast cancer cell proliferation

  2014cited by this paper
• Links between oestrogen receptor activation and proteolysis: relevance to hormone-regulated cancer therapy

  2013cited by this paper
• Derailed estrogen signaling and breast cancer: an authentic couple.

  2013cited by this paper
• Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal

  2013cited by this paper
• Endogenous purification reveals GREB1 as a key estrogen receptor regulatory factor.

  2013cited by this paper
• RNAi silencing targeting RNF8 enhances radiosensitivity of a non-small cell lung cancer cell line A549

  2013cited by this paper
• Links between oestrogen receptor activation and proteolysis: relevance to hormone-regulated cancer therapy

  2013cited by this paper
• Hbo1 is a cyclin E/CDK2 substrate that enriches breast cancer stem-like cells.

  2013cited by this paper
• Molecular Insights into the Function of RING Finger (RNF)-containing Proteins hRNF8 and hRNF168 in Ubc13/Mms2-dependent Ubiquitylation*

  2012cited by this paper
• Comprehensive molecular portraits of human breast tumors

  2012cited by this paper
• Estrogen receptor-α recruits P-TEFb to overcome transcriptional pausing in intron 1 of the MYB gene

  2012cited by this paper
• The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data.

  2012cited by this paper
• The RING Finger Protein RNF8 Ubiquitinates Nbs1 to Promote DNA Double-strand Break Repair by Homologous Recombination*

  2012cited by this paper
• RNF8‐ and RNF168‐dependent degradation of KDM4A/JMJD2A triggers 53BP1 recruitment to DNA damage sites

  2012cited by this paper
• 17β-Estradiol-induced cell proliferation requires estrogen receptor (ER) α monoubiquitination.

  2011cited by this paper
• Oestrogen receptor–co‐factor–chromatin specificity in the transcriptional regulation of breast cancer

  2011cited by this paper
• Estrogen-mediated epigenetic repression of the imprinted gene cyclin-dependent kinase inhibitor 1C in breast cancer cells.

  2011cited by this paper
• Differential regulation of RNF8-mediated Lys48- and Lys63-based poly-ubiquitylation

  2011cited by this paper
• Differential oestrogen receptor binding is associated with clinical outcome in breast cancer

  2011cited by this paper
• Kinome screening for regulators of the estrogen receptor identifies LMTK3 as a new therapeutic target in breast cancer

  2011cited by this paper
• Cracking the estrogen receptor's posttranslational code in breast tumors.

  2011cited by this paper
• The E3 ubiquitin ligase Rnf8 stabilizes Tpp1 to promote telomere end protection

  2011cited by this paper
• RNF8-dependent histone ubiquitination during DNA damage response and spermatogenesis.

  2011cited by this paper
• Liganded and unliganded activation of estrogen receptor and hormone replacement therapies.

  2011cited by this paper
• A p53-independent role of Mdm2 in estrogen-mediated activation of breast cancer cell proliferation

  2011cited by this paper
• RBCK1 drives breast cancer cell proliferation by promoting transcription of estrogen receptor alpha and cyclin B1.

  2010cited by this paper
• Estrogen receptor α (ERα) mediates 17β-estradiol (E2)-activated expression of HBO1

  2010cited by this paper
• RNF8-dependent histone modifications regulate nucleosome removal during spermatogenesis.

  2010cited by this paper
• FHA domain pThr binding specificity: it's all about me.

  2010cited by this paper
• Rnf8 deficiency impairs class switch recombination, spermatogenesis, and genomic integrity and predisposes for cancer

  2010cited by this paper
• Biological determinants of endocrine resistance in breast cancer

  2009cited by this paper
• Corepressive Action of CBP on Androgen Receptor Transactivation in Pericentric Heterochromatin in a Drosophila Experimental Model System

  2008cited by this paper
• Regulation of mitotic exit by the RNF8 ubiquitin ligase

  2008cited by this paper
• A TFTC/STAGA module mediates histone H2A and H2B deubiquitination, coactivates nuclear receptors, and counteracts heterochromatin silencing.

  2008cited by this paper
• Orchestration of the DNA-Damage Response by the RNF8 Ubiquitin Ligase

  2007cited by this paper
• Estrogen receptor alpha is a putative substrate for the BRCA1 ubiquitin ligase.

  2007cited by this paper
• RNF8 transduces the DNA-damage signal via histone ubiquitylation and checkpoint protein assembly.

  2007cited by this paper
• A Conserved Mechanism for Steroid Receptor Translocation to the Plasma Membrane*

  2007cited by this paper
• Estrogen receptor α is a putative substrate for the BRCA1 ubiquitin ligase

  2007cited by this paper
• The RING finger protein RNF8 recruits UBC13 for lysine 63‐based self polyubiquitylation

  2006cited by this paper
• The aryl hydrocarbon receptor constitutively represses c-myc transcription in human mammary tumor cells

  2005cited by this paper
• Tamoxifen resistance by a conformational arrest of the estrogen receptor alpha after PKA activation in breast cancer.

  2004cited by this paper
• Ligand‐dependent switching of ubiquitin–proteasome pathways for estrogen receptor

  2004cited by this paper
• Estrogens and their receptors in breast cancer progression: a dual role in cancer proliferation and invasion.

  2004cited by this paper
• The RING Finger Protein, RNF8, Interacts with Retinoid X Receptor α and Enhances Its Transcription-stimulating Activity*

  2004cited by this paper
• Cyclic, proteasome-mediated turnover of unliganded and liganded ERalpha on responsive promoters is an integral feature of estrogen signaling.

  2003cited by this paper
• Estrogen Receptor Breast Cancer Phenotypes in the Surveillance, Epidemiology, and End Results Database

  2002cited by this paper
• Activation Function-1 Domain of Androgen Receptor Contributes to the Interaction between Subnuclear Splicing Factor Compartment and Nuclear Receptor Compartment

  2002cited by this paper
• Genetic Ablation of the Steroid Receptor Coactivator-Ubiquitin Ligase, E6-AP, Results in Tissue-Selective Steroid Hormone Resistance and Defects in Reproduction

  2002cited by this paper
• Ubiquitin and proteasomes: Themes and variations on ubiquitylation

  2001cited by this paper
• N-Terminally extended human ubiquitin-conjugating enzymes (E2s) mediate the ubiquitination of RING-finger proteins, ARA54 and RNF8.

  2001cited by this paper
• The Human Estrogen Receptor-α Is a Ubiquitinated Protein Whose Stability Is Affected Differentially by Agonists, Antagonists, and Selective Estrogen Receptor Modulators*

  2001cited by this paper
• Mechanisms of estrogen action.

  2001cited by this paper
• RING finger proteins: mediators of ubiquitin ligase activity.

  2000cited by this paper
• The 26S proteasome is required for estrogen receptor-alpha and coactivator turnover and for efficient estrogen receptor-alpha transactivation.

  2000cited by this paper
• ICI 182,780 (Faslodex™)

  2000cited by this paper
• The 26S Proteasome Is Required for Estrogen Receptor-α and Coactivator Turnover and for Efficient Estrogen Receptor-α Transactivation

  2000cited by this paper
• Cofactor dynamics and sufficiency in estrogen receptor-regulated transcription.

  2000cited by this paper
• Proteasome-dependent degradation of the human estrogen receptor.

  1999cited by this paper
• Isolation, tissue expression, and chromosomal assignment of a novel human gene which encodes a protein with RING finger motif

  1998cited by this paper
• This Work Is Licensed under a Creative Commons Attribution 4.0 International License Date Deposited: the Histone Demethylase Enzyme Kdm3a Is a Key Estrogen Receptor Regulator in Breast Cancer

  year unknowncited by this paper
• Estrogen receptor-directly regulates the hypoxia-inducible factor 1 pathway associated with antiestrogen response in breast cancer.

  year unknowncited by this paper

• The emerging regulatory interface between DNA repair and steroid hormone receptors in cancer.

  2025cites this paper
• Decoding estrogen receptor and GPER biology: structural insights and therapeutic advances in ERα−positive breast cancer

  2025cites this paper
• Study on the LINC00578/miR-495-3p/RNF8 axis regulating breast cancer progression

  2025cites this paper
• Stabilization of estrogen receptor α by USP37 contributes to the progression of breast cancer

  2022cites this paper
• The Interplay between the Cellular Response to DNA Double-Strand Breaks and Estrogen

  2022cites this paper
• A functional reference map of the RNF8 interactome in cancer

  2022cites this paper
• Monoubiquitination in Homeostasis and Cancer

  2022cites this paper
• RNF8 up-regulates AR/ARV7 action to contribute to advanced prostate cancer progression

  2022cites this paper
• FKBP52 and FKBP51 differentially regulate the stability of estrogen receptor in breast cancer

  2022cites this paper
• Decoding the Therapeutic Implications of the ERα Stability and Subcellular Distribution in Breast Cancer

  2022cites this paper
• AKTIP loss is enriched in ERα-positive breast cancer for tumorigenesis and confers endocrine resistance

  2022cites this paper
• Ubiquitin-specific peptidase 14 maintains estrogen receptor α stability via its deubiquitination activity in endometrial cancer

  2022cites this paper
• Autophagic Organelles in DNA Damage Response

  2021cites this paper
• Regulation of ERα Stability and Estrogen Signaling in Breast Cancer by HOIL-1

  2021cites this paper
• OTUD7B stabilizes estrogen receptor α and promotes breast cancer cell proliferation

  2021cites this paper
• TRIM3 facilitates estrogen signaling and modulates breast cancer cell progression

  2021cites this paper
• Calcineurin regulates the stability and activity of estrogen receptor α

  2021cites this paper
• RNF8 induces β-catenin-mediated c-Myc expression and promotes colon cancer proliferation

  2020cites this paper
• ZNF213 Facilitates ER Alpha Signaling in Breast Cancer Cells

  2020cites this paper
• Identification of the potential roles of ring finger protein 8 in TP53-mutant breast cancer

  2020cites this paper
• The ubiquitin ligase RNF8 regulates Rho GTPases and promotes cytoskeletal changes and motility in triple‐negative breast cancer cells

  2020cites this paper
• TRIM8 inhibits breast cancer proliferation by regulating estrogen signaling.

  2020cites this paper
• The ubiquitin ligase RNF181 stabilizes ERα and modulates breast cancer progression

  2020cites this paper
• TRIM11 promotes breast cancer cell proliferation by stabilizing estrogen receptor α

  2020cites this paper
• miR-214 inhibits epithelial-mesenchymal transition of breast cancer cells via downregulation of RNF8.

  2019cites this paper
• Regulation of estrogen signaling and breast cancer proliferation by an ubiquitin ligase TRIM56

  2019cites this paper
• The Functions of DNA Damage Factor RNF8 in the Pathogenesis and Progression of Cancer

  2019cites this paper
• Estrogen Receptor Alpha and its Ubiquitination in Breast Cancer Cells.

  2019cites this paper
• RNF168 facilitates proliferation and invasion of esophageal carcinoma, possibly via stabilizing STAT1

  2018cites this paper
• Polyubiquitination inhibition of estrogen receptor alpha and its implications in breast cancer

  2018cites this paper
• Timeless Is a Novel Estrogen Receptor Co-activator Involved in Multiple Signaling Pathways in MCF-7 Cells.

  2018cites this paper
• SMURF1 facilitates estrogen receptor ɑ signaling in breast cancer cells

  2018cites this paper
• Post-Translational Modifications of H2A Histone Variants and Their Role in Cancer

  2018cites this paper
• RNF168 facilitates oestrogen receptor ɑ transcription and drives breast cancer proliferation

  2018influential citation